Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

INR 689.05

(0.15%)

Total Debt Summary of Jagsonpal Pharmaceuticals Limited

  • Jagsonpal Pharmaceuticals Limited's latest annual total debt in 2023 was 89.41 Million INR , up 48.98% from previous year.
  • Jagsonpal Pharmaceuticals Limited's latest quarterly total debt in 2024 Q2 was 16.16 Million INR , down 0.0% from previous quarter.
  • Jagsonpal Pharmaceuticals Limited reported annual total debt of 60.01 Million INR in 2022, down 0.0% from previous year.
  • Jagsonpal Pharmaceuticals Limited reported annual total debt of - INR in 2021, down -100.0% from previous year.
  • Jagsonpal Pharmaceuticals Limited reported quarterly total debt of 89.41 Million INR for 2023 Q4, down 0.0% from previous quarter.
  • Jagsonpal Pharmaceuticals Limited reported quarterly total debt of 89.41 Million INR for 2023 FY, up 48.98% from previous quarter.

Annual Total Debt Chart of Jagsonpal Pharmaceuticals Limited (2023 - 2007)

Historical Annual Total Debt of Jagsonpal Pharmaceuticals Limited (2023 - 2007)

Year Total Debt Total Debt Growth
2023 89.41 Million INR 48.98%
2022 60.01 Million INR 0.0%
2021 - INR -100.0%
2020 67.87 Million INR 45.51%
2019 46.64 Million INR 23.23%
2018 37.85 Million INR -54.4%
2017 83 Million INR 4.7%
2016 79.28 Million INR -79.4%
2015 384.92 Million INR -2.08%
2014 393.1 Million INR 9.32%
2013 359.57 Million INR 7.63%
2012 334.07 Million INR -4.26%
2011 348.93 Million INR 22.03%
2010 285.93 Million INR 41.0%
2009 202.79 Million INR -27.49%
2008 279.65 Million INR -30.75%
2007 403.81 Million INR 0.0%

Peer Total Debt Comparison of Jagsonpal Pharmaceuticals Limited

Name Total Debt Total Debt Difference
Sigachi Industries Limited 1.43 Billion INR 93.75%
Ind-Swift Limited 10.13 Billion INR 99.118%
Bajaj HealthCare Limited 3.32 Billion INR 97.314%
Sakar Healthcare Limited 793.51 Million INR 88.732%
Aurobindo Pharma Limited 66.47 Billion INR 99.866%
Innova Captab Limited 2.45 Billion INR 96.352%
Divi's Laboratories Limited 30 Million INR -198.033%
AstraZeneca Pharma India Limited 45.98 Million INR -94.446%
Morepen Laboratories Limited 289.99 Million INR 69.168%
Mankind Pharma Limited 2.07 Billion INR 95.684%
Sequent Scientific Limited 4.87 Billion INR 98.167%
Wanbury Limited 1.16 Billion INR 92.324%
Laurus Labs Limited 25.77 Billion INR 99.653%
Nectar Lifesciences Limited 6.35 Billion INR 98.593%
Glenmark Life Sciences Limited 171.48 Million INR 47.86%
Alembic Limited 91.5 Million INR 2.284%
Hikal Limited 8.17 Billion INR 98.906%
Alembic Pharmaceuticals Limited 5.13 Billion INR 98.258%
Neuland Laboratories Limited 953.89 Million INR 90.627%
J. B. Chemicals & Pharmaceuticals Limited 3.77 Billion INR 97.633%
Glenmark Pharmaceuticals Limited 12.3 Billion INR 99.274%
IOL Chemicals and Pharmaceuticals Limited 327.6 Million INR 72.708%
Themis Medicare Limited 957.92 Million INR 90.666%
RPG Life Sciences Limited - INR -Infinity%
Zydus Lifesciences Limited 8.04 Billion INR 98.888%
Lupin Limited 29.21 Billion INR 99.694%
Amrutanjan Health Care Limited 17.28 Million INR -417.329%
Wockhardt Limited 23.56 Billion INR 99.621%
Vaishali Pharma Limited 134.91 Million INR 33.73%
Aarti Pharmalabs Limited 2.85 Billion INR 96.866%
Jubilant Pharmova Limited 36.64 Billion INR 99.756%
FDC Limited 205.18 Million INR 56.425%
Dr. Reddy's Laboratories Limited 20.02 Billion INR 99.553%
Kilitch Drugs (India) Limited 316.46 Million INR 71.747%
Eris Lifesciences Limited 27.81 Billion INR 99.679%
Venus Remedies Limited 413.3 Million INR 78.367%
ZIM Laboratories Limited 1.08 Billion INR 91.784%
Bliss GVS Pharma Limited 998.4 Million INR 91.045%
Par Drugs and Chemicals Limited - INR -Infinity%
Caplin Point Laboratories Limited 19.7 Million INR -353.858%
Shilpa Medicare Limited 9.37 Billion INR 99.046%
Albert David Limited 33.24 Million INR -168.967%
Ajanta Pharma Limited 352.8 Million INR 74.657%
Hester Biosciences Limited 2.44 Billion INR 96.341%
Suven Pharmaceuticals Limited 649.96 Million INR 86.244%
Solara Active Pharma Sciences Limited 10.11 Billion INR 99.116%
Gufic Biosciences Limited 3.32 Billion INR 97.314%
Windlas Biotech Limited 36.41 Million INR -145.564%
Procter & Gamble Health Limited 95.6 Million INR 6.475%
Aarey Drugs & Pharmaceuticals Limited 313.52 Million INR 71.482%
Mangalam Drugs & Organics Limited 984.92 Million INR 90.922%
Granules India Limited 13.15 Billion INR 99.32%
Aarti Drugs Limited 5.64 Billion INR 98.415%
Bal Pharma Limited 1.39 Billion INR 93.597%
Alkem Laboratories Limited 14.18 Billion INR 99.37%
Sun Pharmaceutical Industries Limited 32.73 Billion INR 99.727%
Lincoln Pharmaceuticals Limited 10.66 Million INR -738.114%
Medicamen Biotech Limited 308.17 Million INR 70.987%
Unichem Laboratories Limited 2.47 Billion INR 96.388%
Bafna Pharmaceuticals Limited 243.89 Million INR 63.34%
Biofil Chemicals and Pharmaceuticals Limited 4.38 Million INR -1937.138%
Valiant Laboratories Limited 767.08 Million INR 88.344%
Orchid Pharma Limited 1.35 Billion INR 93.386%
Medico Remedies Limited 80.5 Million INR -11.063%
Ind-Swift Laboratories Limited 166.21 Million INR 46.209%
Ipca Laboratories Limited 14.38 Billion INR 99.378%
Brooks Laboratories Limited 56.41 Million INR -58.475%
Syncom Formulations (India) Limited 724.86 Million INR 87.665%
Piramal Enterprises Limited 535.85 Billion INR 99.983%
Torrent Pharmaceuticals Limited 40.22 Billion INR 99.778%
NATCO Pharma Limited 3.71 Billion INR 97.591%
Suven Life Sciences Limited 7.09 Million INR -1159.828%
Krebs Biochemicals & Industries Limited 1.93 Billion INR 95.378%
Strides Pharma Science Limited 25.16 Billion INR 99.645%
Indoco Remedies Limited 6.71 Billion INR 98.669%
Alpa Laboratories Limited 52.46 Million INR -70.418%
Lasa Supergenerics Limited 220.76 Million INR 59.499%
Sun Pharma Advanced Research Company Limited 611.5 Million INR 85.379%